SCHEMBL3370849

SCHEMBL3370849

CCCCCc1c(CCCCC)c2ccsc2c2sccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 5/20 0.49
TLR8 Q9NR97 4/20 0.36
ESR1 P03372 2/20 0.34
ADRA2A P08913 2/20 0.34
ADORA3 P0DMS8 2/20 0.34
TACR2 P21452 2/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 2/20 0.34
KCNH2 Q12809 2/20 0.34
LMNA P02545 1/20 0.34
SHBG P04278 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
HSPD1 P10809 1/20 0.34
ADRB3 P13945 1/20 0.34
HTR2C P28335 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL991721 0.98 GPR35 (0.51) GPR35TLR8ESR1ADRA2AADORA3
SCHEMBL3372174 0.98 GPR35 (0.51) GPR35TLR8ESR1ADRA2AADORA3
SCHEMBL23047279 0.93 GPR35 (0.48) GPR35TLR8ESR1ADRA2AADORA3
SCHEMBL14876496 0.93 GPR35 (0.48) GPR35TLR8ESR1ADRA2AADORA3
SCHEMBL995654 0.90 GPR35 (0.51) GPR35ESR1ADRA2AADORA3TACR2
SCHEMBL3842694 0.90 GPR35 (0.51) GPR35ESR1ADRA2AADORA3TACR2
SCHEMBL336915 0.90 GPR35 (0.51) GPR35ESR1ADRA2AADORA3TACR2
SCHEMBL861104 0.90 GPR35 (0.51) GPR35ESR1ADRA2AADORA3TACR2
SCHEMBL15790575 0.90 GPR35 (0.49) GPR35ESR1ADRA2AADORA3TACR2
SCHEMBL3370732 0.85 KDM4E (0.36) GPR35ADORA3KDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9362505-B2 Fused ring compound and method for producing same, polymer, organic thin film containing those, and organic thin film device and organic thin film transistor comprising such organic thin film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-06-07 US disclosed
US-20150045525-A1 FUSED RING COMPOUND AND METHOD FOR PRODUCING SAME, POLYMER, ORGANIC THIN FILM CONTAINING THOSE, AND ORGANIC THIN FILM DEVICE AND ORGANIC THIN FILM TRANSISTOR COMPRISING SUCH ORGANIC THIN FILM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-02-12 US disclosed
US-8895692-B2 Fused ring compound and method for producing same, polymer, organic thin film containing those, and organic thin film device and organic thin film transistor comprising such organic thin film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-11-25 US disclosed
EP-2192123-B1 FUSED TRICYCLIC COMPOUNDS USEFUL IN ORGANIC THIN FILM DEVICES SUCH AS TRANSISTORS SUMITOMO CHEMICAL CO (JP) 2012-11-21 EP disclosed
US-8299272-B2 Process for production of fused ring compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-30 US disclosed
EP-2006291-B1 FUSED POLYCYCLIC POLYMER, ORGANIC THIN FILM CONTAINING THE POLYMER AND ORGANIC THIN FILM TRANSISTOR COMPRISING THE ORGANIC THIN FILM SUMITOMO CHEMICAL CO (JP) 2010-11-03 EP disclosed
EP-2192123-A1 FUSED TRICYCLIC COMPOUNDS USEFUL IN ORGANIC THIN FILM DEVICES SUCH AS TRANSISTORS Sumitomo Chemical Company, Limited (JP) 2010-06-02 EP disclosed
US-20090156832-A1 PROCESS FOR PRODUCTION OF FUSED RING COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-18 US disclosed
US-20090065770-A1 FUSED RING COMPOUND AND METHOD FOR PRODUCING SAME, POLYMER, ORGANIC THIN FILM CONTAINING THOSE, AND ORGANIC THIN FILM DEVICE AND ORGANIC THIN FILM TRANSISTOR COMPRISING SUCH ORGANIC THIN FILM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-03-12 US disclosed
EP-2006291-A1 FUSED RING COMPOUND AND METHOD FOR PRODUCING SAME, POLYMER, ORGANIC THIN FILM CONTAINING THOSE, AND ORGANIC THIN FILM DEVICE AND ORGANIC THIN FILM TRANSISTOR COMPRISING SUCH ORGANIC THIN FILM Osaka University (JP) 2008-12-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156832-A1 PROCESS FOR PRODUCTION OF FUSED RING COMPOUND SLC39A11, CYP4F11, SLC12A2 GPR35 2629/4885TLR8 4432/4885ESR1 3026/4885
US-20090065770-A1 FUSED RING COMPOUND AND METHOD FOR PRODUCING SAME, POLYMER, ORGANIC THIN FILM CONTAINING THOSE, AND ORGANIC THIN FILM DEVICE AND ORGANIC THIN FILM TRANSISTOR COMPRISING SUCH ORGANIC THIN FILM SLC43A1, SLC39A11, SLC7A5 GPR35 4002/4885TLR8 4597/4885ESR1 2508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.